NASA
Stagnant or reverse flow in the internal jugular vein has been observed in 6 of 11 crew members (55%) tested in-mission on approximately flight day 50; one crewmember was found to have an occlusive internal jugular vein thrombus requiring treatment in-mission. This is an emerging finding and has potential impacts on flight participants with cardiovascular conditions.
Directed Acyclic Graph Files
+ DAG File Information (HSRB Home Page)